Jesuloba Abiola
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Jesuloba Abiola has a total of 20 co-authors. Here are the top co-authors by number of shared publications:
- Panagiotis Kafas
Department of Oral Surgery and Radiology, School of Dentistry, Aristotle University, Thessalonica, Greece
4 shared publications - Tahwinder Upile
Barnet and Chase Farm Hospital
4 shared publications - Waseem Jerjes
Faculty of Medicine Imperial College London London UK
4 shared publications - Colin Hopper
Unit of OMFS, UCL Eastman Dental Institute, London WC1E 6DE, UK
3 shared publications - Hani Radhi
Department of Oral Surgery Mustansiriyah University Baghdad Iraq
3 shared publications - Aidan Adams
Leeds Institute of Molecular Medicine, School of Medicine, University of Leeds, Leeds, UK
2 shared publications
Latest Publications
- Open Access
- 13 June 2012
- Published by Springer Nature in Head & Neck Oncology
- Vol. 4 (1) , 33
A patient with primary Burkitt’s lymphoma of the postnasal space: case report
- 13 June 2012
- Published by Springer Nature in Head & Neck Oncology
- Vol. 4 (1) , 33
Open AccessA patient with primary Burkitt’s lymphoma of the postnasal space: case report
- Open Access
- 12 March 2012
- Published by Springer Nature in Head & Neck Oncology
- Vol. 4 (1) , 6
The effect of tobacco and alcohol and their reduction/cessation on mortality in oral cancer patients: short communication
The use of tobacco is known to increase the incidence of developing oral cancer by 6 times, while the additive effect of drinking alcohol further increases the risk leading to higher rate of morbidity and mortality. In this short communication, we prospectively assessed the effect of tobacco smoking and alcohol drinking in oral cancer patients on the overall mortality from the disease, as well as the effect of smoking and drinking reduction/cessation at time of diagnosis on mortality in the same group.
- 12 March 2012
- Published by Springer Nature in Head & Neck Oncology
- Vol. 4 (1) , 6
Open AccessThe effect of tobacco and alcohol and their reduction/cessation on mortality in oral cancer patients: short communication
The use of tobacco is known to increase the incidence of developing oral cancer by 6 times, while the additive effect of drinking alcohol further increases the risk leading to higher rate of morbidity and mortality. In this short communication, we prospectively assessed the effect of tobacco smoking and alcohol drinking in oral cancer patients on the overall mortality from the disease, as well as the effect of smoking and drinking reduction/cessation at time of diagnosis on mortality in the same group.
- Open Access
- 12 March 2012
- Published by Springer Nature in Head & Neck Oncology
- Vol. 4 (1) , 5
cTNM vs. pTNM: the effect of not applying ultrasonography in the identification of cervical nodal disease
- 12 March 2012
- Published by Springer Nature in Head & Neck Oncology
- Vol. 4 (1) , 5
Open AccesscTNM vs. pTNM: the effect of not applying ultrasonography in the identification of cervical nodal disease
- Open Access
- 24 October 2009
- Published by Springer Nature in Head & Face Medicine
- Vol. 5 (1) , 20
Unilateral versus bilateral thyroarytenoid Botulinum toxin injections in adductor spasmodic dysphonia: a prospective study
In this preliminary prospective study, we compared unilateral and bilateral thyroarytenoid muscle injections of Botulinum toxin (Dysport) in 31 patients with adductor spasmodic dysphonia, who had undergone more than 5 consecutive Dysport injections (either unilateral or bilateral) and had completed 5 concomitant self-rated efficacy and complication scores questionnaires related to the previous injections. We also developed a Neurophysiological Scoring (NPS) system which has utility in the treatment administration. Data were gathered prospectively on voice improvement (self-rated 6 point scale), length of response and duration of complications (breathiness, cough, dysphagia and total voice loss). Injections were performed under electromyography (EMG) guidance. NPS scale was used to describe the EMG response. Dose and unilateral/bilateral injections were determined by clinical judgment based on previous response. Time intervals between injections were patient driven. Low dose unilateral Dysport injection was associated with no significant difference in the patient's outcome in terms of duration of action, voice score (VS) and complication rate when compared to bilateral injections. Unilateral injections were not associated with any post treatment total voice loss unlike the bilateral injections. Unilateral low dose Dysport injections are recommended in the treatment of adductor spasmodic dysphonia.
- 24 October 2009
- Published by Springer Nature in Head & Face Medicine
- Vol. 5 (1) , 20
Open AccessUnilateral versus bilateral thyroarytenoid Botulinum toxin injections in adductor spasmodic dysphonia: a prospective study
In this preliminary prospective study, we compared unilateral and bilateral thyroarytenoid muscle injections of Botulinum toxin (Dysport) in 31 patients with adductor spasmodic dysphonia, who had undergone more than 5 consecutive Dysport injections (either unilateral or bilateral) and had completed 5 concomitant self-rated efficacy and complication scores questionnaires related to the previous injections. We also developed a Neurophysiological Scoring (NPS) system which has utility in the treatment administration. Data were gathered prospectively on voice improvement (self-rated 6 point scale), length of response and duration of complications (breathiness, cough, dysphagia and total voice loss). Injections were performed under electromyography (EMG) guidance. NPS scale was used to describe the EMG response. Dose and unilateral/bilateral injections were determined by clinical judgment based on previous response. Time intervals between injections were patient driven. Low dose unilateral Dysport injection was associated with no significant difference in the patient's outcome in terms of duration of action, voice score (VS) and complication rate when compared to bilateral injections. Unilateral injections were not associated with any post treatment total voice loss unlike the bilateral injections. Unilateral low dose Dysport injections are recommended in the treatment of adductor spasmodic dysphonia.